Amelioration of disordered hepatic protein synthesis by the deleted form of hepatocyte growth factor in models of liver failure in rats

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 8, 1996, Pages 876-879

  Masunaga, Hiroaki ^a   Fujise, Nobuaki ^a   Shiota, Akira ^a   Yamashita, Yasushi ^a   Yasuda, Hiroshi ^a   Higashio, Kanji ^a  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CARBON TETRACHLORIDE; DIMETHYLNITROSAMINE; GALACTOSAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER PROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PLASMA PROTEIN; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING TIME; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HYPOPROTEINEMIA; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; LIVER NECROSIS; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PROTEIN SYNTHESIS; RAT;

EID: 0029832968     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb03991.x     Document Type: Article

References (26)

1. Ala-Kokko, L., Stenbäck, F., Ryhänen, L. (1989) Preventive effect of malotinate on dimethylnitrosamine-induced liver fibrosis in the rat. J. Lab. Clin. Med. 113: 177-183
2. Brown, M. S., Goldstein, J. L. (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47
3. Bucher, N. L. R., Swaffield, M. N. (1975) Regulation of hepatic regeneration in rats: synergistic action of insulin and glucagon. Proc. Nat. Acad. Sci. USA 72: 1157-1160
4. Bucher, N. L. R., Patel, U., Cohen, S. (1978) Hormonal factors and liver growth. Adv. Enzyme Regul. 16: 205-213
5. Burton, K. (1956) A study of the conditions and mechanism of the diphenylamine reaction for the calorimetric estimation of deoxyribonucleic acid. Biochem. J. 62: 315-323
6. Calandra, S., Martin, M. J., McIntyre, N. (1971) Plasma lecithin : cholesterol acyltransferase activity in liver disease. Eur. J. Clin. Invest. 1: 352-360
7. Dietschy, J. M., Wilson, J. D. (1970) Regulation of cholesterol metabolism. N. Engl. J. Med. 282: 1128-1141
8. Fujiwara, K., Nagoshi, S., Ohno, A., Hirata, K., Ohta, Y., Mochida, S., Tomiya, T., Higashio, K., Kurokawa, K. (1993) Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 18: 1443-1449
9. Gromset, J. H., Wright, J. L. (1981) Assay for lecithin : cholesterol acyltransferase. In: Colowick, S. P., Caplan, N. O. (eds) Methods in Enzymology, vol. 72. Academic Press, New York, pp 377-378
10. Higashio, K., Shima, N., Goto, M., Itagaki, Y., Nagao, M., Yasuda, H., Morinaga, T. (1990) Identity of a tumour cytotoxic factor from human fibroblasts and hepatocyte growth factor. Biochem. Biophys. Res. Commun. 170: 397-404
11. Higgins, G. M., Anderson, R. M. (1931) Experimental pathology of the liver: restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 12: 186-202
12. Ishiki, Y., Ohnishi, H., Muto, Y., Matsumoto, K., Nakamura, T. (1992) Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16: 1227-1235
13. Majumdar, C., Tsukada, K., Lieberman, I. (1967) Liver protein synthesis after partial hepatectomy and acute stress. J. Biol. Chem. 242: 700-704
14. Mead, J. E., Fausto, N. (1989) Transforming growth factor-α may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc. Nat. Acad. Sci. USA 86: 1558-1562
15. Mostafa, M. H., Ruchirawat, M., Weisburger, E. K. (1981) Effect of indole on N-nitrosodimethylamine demethylase in rats treated with carbon tetrachloride. Food Cosmet. Toxicol. 19: 717-721
16. Nakamura, T., Nawa, K., Ichihara, A. (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122: 1450-1459
17. Olsen, P. S., Boesby, S., Kirkegaard, P., Therkelsen, K., Almdal, T., Poulsen, S. S., Nexø, E. (1988) Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 8: 992-996
18. Radding, C. M., Bragdon, J. H., Steinberg, D. (1958) The synthesis of low- and high-density lipoproteins by rat liver in vitro. Biochim. Biophys. Acta 30: 443-444
19. Roos, F., Terrell, T. G., Godowski, P. J., Steven, M. C., Schwall, R. H. (1992) Reduction of α-naphthylisothiocyanate-induced hepatotoxicity by recombinant human hepatocyte growth factor. Endocrinology 131: 2540-2544
20. Russell, W. E., coffey, R. J., Quellette, A.J., Moses, H. L. (1988) Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Nat. Acad. Sci. USA 85: 5126-5130
21. Shima, N., Nagao, M., Ogaki, F., Tsuda, E., Murakami, A., Higashio, K. (1991a) Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein. Biochem. Biophys. Res. Commun. 180: 1151-1158
22. Shima, N., Higashio, K., Ogaki, H., Okabe, K. (1991b) ELISA for F-TCF (human hepatocyte growth factor/hHGF)/fibroblast-derived tumor cytotoxic factor antigen employing monoclonal antibodies and its application to patients with liver diseases. Gastroenterologia Japonica 26: 477-482
23. Shima, N., Tsuda, E., Goto, M., Yano, K., Hayasaka, H., Ueda, M., Higashio, K. (1994) Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable by their biological activity and tertiary structure. Biochem. Biophys. Res. Commun. 200: 808-815
24. Stachura, J., Tarnawski, A., Ivey, K. J., Mach, T., Bogdal, J., Szczudrawa, J., Klimczyk, B. (1981) Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 81: 211-217
25. Strandberg, T. E., Tilvis, R. S., Miettinen, T. A. (1984) Diurnal variation of plasma methyl sterols and cholesterol in the rat-relation to hepatic cholesterol synthesis. Lipids 19: 202-205
26. Yoshitake, I., Ohishi, E., Kubo, K. (1991) Hepatoprotective effects of 1-[(2-thiazolin-2-y1)-amino]acetyl-4-(1,3-dithiol-2-ylidene)-2,3,4,5-tetrahydro- 1H-1-benzazepin-3,5-dione hydrochloride (KF-14363) in various experimental liver injuries. Jpn J. Pharmacol. 57: 127-136